Eiken Chemical Co., Ltd. (TYO:4549)

Eiken Chemical Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 5, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	80,409	76,821	71,196	57,776	63,838	79,880
Market Cap Growth	8.50%	7.90%	23.23%	-9.50%	-20.08%	9.89%
Enterprise Value	73,876	71,948	56,470	41,055	56,592	72,790
Last Close Price	2439.00	2239.48	1932.84	1464.34	1568.56	1913.18
PE Ratio	21.10	34.48	27.03	10.07	10.27	15.84
Forward PE	24.54	23.55	20.74	11.33	11.99	16.21
PS Ratio	1.95	1.90	1.78	1.34	1.49	2.07
PB Ratio	1.83	1.76	1.55	1.17	1.39	1.92
P/TBV Ratio	1.85	1.79	1.58	1.19	1.44	1.99
P/FCF Ratio	175.95	93.80	38.91	13.22	19.11	20.50
P/OCF Ratio	20.04	12.73	18.71	7.63	8.22	14.65
PEG Ratio	-	0.87	0.87	0.87	0.87	0.87
EV/Sales Ratio	1.79	1.78	1.41	0.95	1.32	1.88
EV/EBITDA Ratio	13.74	13.61	9.90	4.29	5.42	8.74
EV/EBIT Ratio	23.70	23.98	16.71	5.51	6.75	11.01
EV/FCF Ratio	161.66	87.85	30.86	9.40	16.94	18.68
Debt / Equity Ratio	0.07	0.10	0.09	0.09	0.09	0.03
Debt / EBITDA Ratio	0.55	0.84	0.76	0.45	0.40	0.14
Debt / FCF Ratio	6.57	5.45	2.37	0.99	1.25	0.30
Asset Turnover	0.65	0.65	0.63	0.67	0.73	0.73
Inventory Turnover	2.79	2.90	2.83	2.74	2.80	2.70
Quick Ratio	1.42	1.53	2.57	2.39	2.27	1.71
Current Ratio	2.17	2.19	3.34	3.15	2.96	2.35
Return on Equity (ROE)	8.63%	4.98%	5.52%	12.03%	14.22%	12.77%
Return on Assets (ROA)	3.14%	3.02%	3.30%	7.24%	8.87%	7.80%
Return on Capital (ROIC)	4.10%	3.81%	4.06%	8.98%	11.30%	10.16%
Return on Capital Employed (ROCE)	6.50%	6.30%	6.70%	13.90%	16.80%	15.40%
Earnings Yield	4.85%	2.90%	3.70%	9.93%	9.74%	6.31%
FCF Yield	0.57%	1.07%	2.57%	7.56%	5.23%	4.88%
Dividend Yield	2.39%	2.37%	2.64%	3.48%	3.25%	2.14%
Payout Ratio	46.23%	80.75%	73.16%	35.44%	27.32%	23.39%
Buyback Yield / Dilution	5.84%	6.43%	0.62%	-0.12%	-0.10%	-0.09%
Total Shareholder Return	8.23%	8.80%	3.26%	3.36%	3.15%	2.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.